MARY HARRISON: Open Payments
NPI 1003244021 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$981 in 37 payments from 14 companies in 2025. Trend: 2023 $452 · 2024 $1,148 · 2025 $981
Food & beverage: $981
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 7 | $278 |
| Axsome Therapeutics, Inc. | 5 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| HARMONY BIOSCIENCES LLC | 3 | $69 |
| Grifols USA, LLC | 3 | $68 |
| JAZZ PHARMACEUTICALS INC. | 2 | $61 |
| United Therapeutics Corporation | 1 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Viatris Specialty LLC | 2 | $42 |
Products named: Ohtuvayre, DUPIXENT, Sunosi, WAKIX, XYWAV, Remodulin, CUVITRU, TEZSPIRE.
Industry payments across GA — which companies pay providers there.
